Cargando…

Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors

Cancer is a disease characterized by the continuous growth of cells without adherence to the rules that healthy normal cells obey. Carbonic anhydrase I and II (CA I and CA II) inhibitors are used for the treatment of some diseases. The available drugs in the market have limitations or side effects,...

Descripción completa

Detalles Bibliográficos
Autores principales:	TUĞRAK, Mehtap, GÜL, Halise İnci, SAKAGAMİ, Hiroshi, KAYA, Rüya, GÜLÇİN, İlhami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Scientific and Technological Research Council of Turkey 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8326471/ https://www.ncbi.nlm.nih.gov/pubmed/34385849 http://dx.doi.org/10.3906/kim-2009-37

Ejemplares similares

Synthesis and pharmacological effects of novel benzenesulfonamides carrying benzamide moiety as carbonic anhydrase and acetylcholinesterase inhibitors
por: TUĞRAK, Mehtap, et al.
Publicado: (2020)

Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties
por: Bilginer, Sinan, et al.
Publicado: (2019)

Microwave-assisted synthesis and bioevaluation of new sulfonamides
por: Gul, Halise Inci, et al.
Publicado: (2017)

Synthesis, cytotoxicities, and carbonic anhydrase inhibition potential of 6-(3-aryl-2-propenoyl)-2(3H)-benzoxazolones
por: Bilginer, Sinan, et al.
Publicado: (2019)

Synthesis, carbonic anhydrase I and II inhibition studies of the 1,3,5-trisubstituted-pyrazolines
por: Gul, Halise Inci, et al.
Publicado: (2016)

Synthesis and bioactivities of 1-(4-hydroxyphenyl)-2-((heteroaryl)thio)ethanones as carbonic anhydrase I, II and acetylcholinesterase inhibitors
por: YAMALI, Cem, et al.
Publicado: (2020)

Dependence on linkers’ flexibility designed for benzenesulfonamides targeting discovery of novel hCA IX inhibitors as potent anticancer agents
por: Tawfik, Haytham O., et al.
Publicado: (2022)

Designing, synthesis and bioactivities of 4-[3-(4-hydroxyphenyl)-5-aryl-4,5-dihydro-pyrazol-1-yl]benzenesulfonamides
por: Gul, Halise Inci, et al.
Publicado: (2016)

Chromosomal Location of HCA1 and HCA2, Hybrid Chlorosis Genes in Rice
por: Ichitani, Katsuyuki, et al.
Publicado: (2012)

Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development
por: Aljanabi, Reem, et al.
Publicado: (2021)

Novel sulphonamide-bearing methoxyquinazolinone derivatives as anticancer and apoptosis inducers: synthesis, biological evaluation and in silico studies
por: Alqahtani, Ali S., et al.
Publicado: (2021)

Smallpox and Sulphonamide
por: Patel, T. B., et al.
Publicado: (1940)

Sulphonamide Anuria
por: Rai, T. N.
Publicado: (1946)

Sulphonamides and Sulphones
Publicado: (1950)

Sulphonamides and Quinine
por: Niblock, W.
Publicado: (1944)

Induction of HCA587-Specific Antitumor Immunity with HCA587 Protein Formulated with CpG and ISCOM in Mice
por: Chen, Juanjuan, et al.
Publicado: (2012)

ANTIBIOTIC AND SULPHONAMIDE TREATMENT
Publicado: (1960)

ANTIBIOTICS AND SULPHONAMIDES IN PÆDIATRICS
Publicado: (1962)

The Sulphonamides in Bacillary Dysentery
Publicado: (1945)

The Sulphonamides in Theory and Practice
Publicado: (1946)

Sulphonamides in Bronchial Secretion
Publicado: (1945)

Sulphonamides in Undulant Fever
por: Bardhan, P. N.
Publicado: (1943)

Sulphonamides in Topical Application
por: Hamburger, H. J.
Publicado: (1942)

Incompatibility of Sulphonamides and Quinine
Publicado: (1944)

Incompatibility of Sulphonamides and Quinine
por: Ghose, K. C.
Publicado: (1944)

Sulphonamides in General Practice
Publicado: (1941)

Sulphonamides in Peritoneal Surgery
por: Luthra, P. N.
Publicado: (1945)

Screening of Carbonic Anhydrase, Acetylcholinesterase, Butyrylcholinesterase, and α-Glycosidase Enzyme Inhibition Effects and Antioxidant Activity of Coumestrol
por: Durmaz, Lokman, et al.
Publicado: (2022)

Updates on Antiobesity Effect of Garcinia Origin (−)-HCA
por: Chuah, Li Oon, et al.
Publicado: (2013)

Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair
por: Matsuda, Hiroyuki, et al.
Publicado: (2014)

New peptide derived antimalaria and antimicrobial agents bearing sulphonamide moiety
por: Ugwuja, D. I., et al.
Publicado: (2019)

Synthesis and Molecular Docking of New N-Acyl Hydrazones-Benzimidazole as hCA I and II Inhibitors
por: Küçükoğlu, Kaan, et al.
Publicado: (2023)

Evaluation of the anticancer potential of a sulphonamide carbonic anhydrase IX inhibitor on cervical cancer cells
por: Koyuncu, Ismail, et al.
Publicado: (2019)

Mammalian neurotoxins, Blarina paralytic peptides, cause hyperpolarization of human T-type Ca channel hCa(v)3.2 activation
por: Yano, Yusuke, et al.
Publicado: (2023)

Liver Extract and Sulphonamides in Smallpox
por: Chari, N. N.
Publicado: (1942)

Limitations of Sulphonamide Therapy in Surgery
Publicado: (1945)

Insights into the binding mode of sulphamates and sulphamides to hCA II: crystallographic studies and binding free energy calculations
por: De Simone, Giuseppina, et al.
Publicado: (2017)

Identification of non-classical hCA XII inhibitors using combination of computational approaches for drug design and discovery
por: Al-Sanea, Mohammad M., et al.
Publicado: (2021)

Synthesis, characterisation, biological evaluation and in silico studies of sulphonamide Schiff bases
por: Durgun, Mustafa, et al.
Publicado: (2020)

Design, synthesis, and molecular docking of cysteine-based sulphonamide derivatives as antimicrobial agents
por: Egbujor, Melford C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_shpgd1gnsj1ltohcm1kqt4m4mp